Literature DB >> 9507012

Platelet-derived growth factor stimulates protein kinase D through the activation of phospholipase Cgamma and protein kinase C.

J Van Lint1, Y Ni, M Valius, W Merlevede, J R Vandenheede.   

Abstract

Platelet-derived growth factor (PDGF) stimulates protein kinase D (PKD) in a time- and dose-dependent manner. We have used a series of PDGF receptor mutants that display a selective impairment of the binding of SH2-containing proteins (GTPase-activating protein, SHP-2, phospholipase Cgamma (PLCgamma), or phosphatidylinositol 3'-kinase (PI3K)) to show that Tyr-1021, the PLCgamma-binding site, is essential for PKD stimulation by PDGF in A431 cells. We next investigated whether any one of these four binding sites could mediate PKD activation in the absence of the other three sites. F5, a receptor mutant that lacks all four binding sites for GTPase-activating protein, PLCgamma, PI3K, and SHP-2, fails to activate PKD. A panel of single add-back mutants was used to investigate if any one of these four sites could restore signaling to PKD. Of the four sites, only the PLCgamma+ single add-back receptor restored PDGF-mediated activation of PKD, and only this add-back receptor produced diacylglycerol (DAG) in a PDGF-dependent manner. 1,2-Dioctanoyl-sn-glycerol, a membrane-permeant DAG analog, was found to be sufficient for activation of PKD. Taken together, these data indicate that PLCgamma activation is not only necessary, but also sufficient to mediate PDGF-induced PKD activation. Although the presence of a pleckstrin homology domain makes PKD a potential PI3K target, PKD was not stimulated by selective PI3K activation, and wortmannin, an inhibitor of PI3K, did not inhibit PDGF signaling to PKD. The activation of PKD by DAG or by the wild-type and PLCgamma+ add-back PDGF receptors was inhibited by GF109203X, suggesting a role for protein kinase C in the stimulation of PKD by PDGF. PDGF induced a time-dependent phosphorylation of PKD that closely correlated with activation. The PDGF-induced activation and phosphorylation of PKD were reversed by in vitro incubation of PKD with protein phosphatase 1 or 2A, indicating that PDGF signaling to PKD involves the Ser/Thr phosphorylation of PKD. Taken together, these results conclusively show that PDGF activates PKD through a pathway that involves activation of PLCgamma and, subsequently, protein kinase C.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9507012     DOI: 10.1074/jbc.273.12.7038

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Mechanistic analysis of the amplification and diversification events induced by Vav proteins in B-lymphocytes.

Authors:  María J Caloca; José L Zugaza; Xosé R Bustelo
Journal:  J Biol Chem       Date:  2008-10-29       Impact factor: 5.157

2.  Involvement of protein kinase D in Fc gamma-receptor activation of the NADPH oxidase in neutrophils.

Authors:  Jan K Davidson-Moncada; Guillermo Lopez-Lluch; Anthony W Segal; Lodewijk V Dekker
Journal:  Biochem J       Date:  2002-04-01       Impact factor: 3.857

3.  Spatial and temporal regulation of protein kinase D (PKD).

Authors:  S A Matthews; T Iglesias; E Rozengurt; D Cantrell
Journal:  EMBO J       Date:  2000-06-15       Impact factor: 11.598

4.  CCK causes PKD1 activation in pancreatic acini by signaling through PKC-delta and PKC-independent pathways.

Authors:  Marc J Berna; K Martin Hoffmann; Jose A Tapia; Michelle Thill; Andrea Pace; Samuel A Mantey; Robert T Jensen
Journal:  Biochim Biophys Acta       Date:  2006-12-24

5.  Sequential protein kinase C (PKC)-dependent and PKC-independent protein kinase D catalytic activation via Gq-coupled receptors: differential regulation of activation loop Ser(744) and Ser(748) phosphorylation.

Authors:  Rodrigo Jacamo; James Sinnett-Smith; Osvaldo Rey; Richard T Waldron; Enrique Rozengurt
Journal:  J Biol Chem       Date:  2008-03-12       Impact factor: 5.157

Review 6.  A potent immunosuppressive retroviral peptide: cytokine patterns and signaling pathways.

Authors:  Soichi Haraguchi; Robert A Good; Noorbibi K Day-Good
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

7.  Molecular cloning, epigenetic regulation, and functional characterization of Prkd1 gene promoter in dopaminergic cell culture models of Parkinson's disease.

Authors:  Muhammet Ay; Huajun Jin; Dilshan S Harischandra; Arunkumar Asaithambi; Arthi Kanthasamy; Vellareddy Anantharam; Anumantha G Kanthasamy
Journal:  J Neurochem       Date:  2015-08-28       Impact factor: 5.372

8.  Protein kinase Cdelta selectively regulates protein kinase D-dependent activation of NF-kappaB in oxidative stress signaling.

Authors:  Peter Storz; Heike Döppler; Alex Toker
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

9.  Mitochondrial diacylglycerol initiates protein-kinase D1-mediated ROS signaling.

Authors:  Catherine F Cowell; Heike Döppler; Irene K Yan; Angelika Hausser; Yoshio Umezawa; Peter Storz
Journal:  J Cell Sci       Date:  2009-03-03       Impact factor: 5.285

10.  Characterization of EVL-I as a protein kinase D substrate.

Authors:  Katrien Janssens; Line De Kimpe; Michele Balsamo; Sandy Vandoninck; Jackie R Vandenheede; Frank Gertler; Johan Van Lint
Journal:  Cell Signal       Date:  2008-10-29       Impact factor: 4.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.